Private Portfolio Partners LLC Pfizer Inc Transaction History

Private Portfolio Partners LLC

  • $529 Million
  • Q3 2024

A detailed history of Private Portfolio Partners LLC transactions in Pfizer Inc stock. As of the latest transaction made, Private Portfolio Partners LLC holds 30,966 shares of PFE stock, worth $812,547. This represents 0.17% of its overall portfolio holdings.

Number of Shares
30,966
Holding current value
$812,547
% of portfolio
0.17%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$27.7 - $31.39 $857,758 - $972,022
30,966 New
30,966 $896,000
Q1 2024

May 09, 2024
BUY
$25.89 - $29.73 $134,809 - $154,804
5,207 Added 29.9%
22,619 $627,000
Q4 2023

Feb 07, 2024
SELL
$26.13 - $33.94 $11,680 - $15,171
-447 Reduced 2.5%
17,412 $501,000
Q3 2023

Nov 14, 2023
BUY
$32.09 - $37.51 $7,669 - $8,964
239 Added 1.36%
17,859 $592,000
Q2 2023

Aug 14, 2023
BUY
$36.12 - $41.79 $25,356 - $29,336
702 Added 4.15%
17,620 $646,000
Q1 2023

May 12, 2023
SELL
$39.39 - $51.28 $18,001 - $23,434
-457 Reduced 2.63%
16,918 $690,000
Q4 2022

Feb 01, 2023
SELL
$41.75 - $54.5 $62,959 - $82,186
-1,508 Reduced 7.99%
17,375 $890,000
Q3 2022

Mar 14, 2023
SELL
$43.76 - $53.42 $30,238 - $36,913
-691 Reduced 3.53%
18,883 $826,000
Q3 2022

Nov 07, 2022
SELL
$43.76 - $53.42 $30,281 - $36,966
-692 Reduced 3.54%
18,883 $826,000
Q2 2022

Mar 14, 2023
SELL
$46.53 - $55.17 $65,560 - $77,734
-1,409 Reduced 6.71%
19,574 $1.03 Million
Q2 2022

Aug 02, 2022
SELL
$46.53 - $55.17 $65,514 - $77,679
-1,408 Reduced 6.71%
19,575 $1.03 Million
Q1 2022

Mar 14, 2023
BUY
$45.75 - $56.69 $73,794 - $91,440
1,613 Added 8.33%
20,983 $1.09 Million
Q1 2022

May 12, 2022
BUY
$45.75 - $56.69 $73,794 - $91,440
1,613 Added 8.33%
20,983 $1.09 Million
Q4 2021

Mar 14, 2023
BUY
$41.32 - $61.25 $7,313 - $10,841
177 Added 0.92%
19,370 $1.14 Million
Q4 2021

Feb 14, 2022
BUY
$41.32 - $61.25 $7,272 - $10,780
176 Added 0.92%
19,370 $1.14 Million
Q3 2021

Mar 14, 2023
BUY
$39.25 - $50.42 $181,413 - $233,041
4,622 Added 31.72%
19,193 $825,000
Q3 2021

Nov 04, 2021
BUY
$39.25 - $50.42 $181,452 - $233,091
4,623 Added 31.73%
19,194 $826,000
Q2 2021

Mar 14, 2023
BUY
$35.91 - $40.68 $65,463 - $74,159
1,823 Added 14.3%
14,571 $570,000
Q2 2021

Aug 11, 2021
BUY
$35.91 - $40.68 $65,428 - $74,118
1,822 Added 14.29%
14,571 $571,000
Q1 2021

Mar 14, 2023
SELL
$33.49 - $37.77 $4,085 - $4,607
-122 Reduced 0.95%
12,748 $461,000
Q1 2021

May 17, 2021
SELL
$33.49 - $37.77 $4,052 - $4,570
-121 Reduced 0.94%
12,749 $462,000
Q4 2020

Mar 14, 2023
SELL
$33.47 - $42.56 $215,914 - $274,554
-6,451 Reduced 33.39%
12,870 $473,000
Q4 2020

Feb 16, 2021
SELL
$33.47 - $42.56 $215,948 - $274,597
-6,452 Reduced 33.39%
12,870 $474,000
Q3 2020

Mar 14, 2023
BUY
$31.75 - $37.25 $61,785 - $72,488
1,946 Added 11.2%
19,321 $672,000
Q3 2020

Nov 16, 2020
BUY
$31.75 - $37.25 $348,456 - $408,818
10,975 Added 131.48%
19,322 $709,000
Q2 2020

Aug 14, 2020
SELL
$30.12 - $36.54 $111,504 - $135,271
-3,702 Reduced 30.72%
8,347 $273,000
Q1 2020

May 14, 2020
BUY
$27.03 - $38.62 $18,839 - $26,918
697 Added 6.14%
12,049 $393,000
Q4 2019

Feb 12, 2020
SELL
$32.92 - $37.36 $18,566 - $21,071
-564 Reduced 4.73%
11,352 $445,000
Q3 2019

Nov 13, 2019
SELL
$32.49 - $42.13 $317,654 - $411,905
-9,777 Reduced 45.07%
11,916 $428,000
Q2 2019

Aug 14, 2019
BUY
$36.98 - $41.52 $76,770 - $86,195
2,076 Added 10.58%
21,693 $939,000
Q1 2019

May 10, 2019
BUY
$37.5 - $41.2 $25,087 - $27,562
669 Added 3.53%
19,617 $833,000
Q4 2018

Feb 13, 2019
BUY
$38.47 - $43.86 $728,929 - $831,059
18,948 New
18,948 $827,000

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.73B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Private Portfolio Partners LLC Portfolio

Follow Private Portfolio Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Portfolio Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Portfolio Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email